EFFICACY OF RIFAXIMIN ON BLOATING IN PATIENTS WITH DIARRHOEA-PREDOMINANT IRRITABLE BOWEL SYNDROME: A POOLED ANALYSIS OF THREE PHASE 3, RANDOMIZED, PLACEBO-CONTROLLED TRIALS

Brian Lacy  1     Mark Pimentel  2     Christopher Chang  3     Zeev Heimanson  4     Anthony J. Lembo  5    
1 Mayo Clinic Hospital, Jacksonville, United States
2 Cedars-Sinai Medical Center, Los Angeles, United States
3 New Mexico VA Health Care System, Albuquerque, United States
4 Salix Pharmaceuticals, Bridgewater, United States
5 Beth Israel Deaconess Medical Center, Boston, United States

Session
IBS II

Conference
UEG Week Virtual 2020

Citation
United European Gastroenterology Journal 2020; 8 (Supplement 1)

Login to access library content

Login

Do you need help setting up your myUEG account?
Contact us at [email protected]

New to myUEG?

Create myUEG account

Social Sharing